Home / Services / By Technology / Gene Editing Services / CRISPR-based Gene Editing Services / CRISPR/Cas9 Knockout Libraries
Trusted by Leading Research & Pharma Institutions

CRISPR/Cas9 Knockout Libraries

Accelerate your functional genomics research with genome-wide CRISPR/Cas9 knockout libraries. Our comprehensive platform delivers high-quality sgRNA libraries with validated efficiency for robust genetic screening in drug discovery and target validation.

Genome-Wide Coverage
NGS Verified
High Knockout Efficiency
Learn More

Trusted by leading research and pharmaceutical institutions

Stanford
Roche
MIT
Pfizer
Johns Hopkins
Novartis

Why Choose Our Libraries

Validated sgRNA designs with high on-target activity
Comprehensive genome coverage with multiple sgRNAs per gene
Rigorous quality control with NGS verification
20K+
Genes Covered
4-6
sgRNAs per Gene
≥90%
Knockout Efficiency
98%+
Library Coverage
Service Overview

Comprehensive CRISPR/Cas9 Knockout Library Solutions

Our CRISPR/Cas9 knockout libraries enable genome-wide loss-of-function screening with validated efficiency and comprehensive coverage for drug discovery and functional genomics research.

Pooled Lentiviral Libraries

High-titer lentiviral pooled libraries enable efficient transduction into a wide range of cell types including difficult-to-transfect and primary cells. Each library undergoes rigorous quality control with NGS verification to ensure uniform representation.

  • Genome-wide and targeted subpool options
  • Multiple sgRNAs per gene for robust knockout
  • Lentiviral delivery for broad cell type compatibility

Arrayed Library Screening

Arrayed formats enable high-content phenotypic screening without the need for NGS deconvolution. Ready-to-transfect synthetic guides simplify workflows and accelerate discovery timelines.

  • Binary and multiparametric functional assays
  • Standard PCR/Sanger quantification
  • Flexible plate formats available

Validated sgRNA Design

Computationally optimized sgRNAs with proven on-target activity and minimized off-target effects using established design algorithms.

NGS Quality Verification

Every library undergoes next-generation sequencing verification with detailed QC reports for complete transparency.

Custom Library Design

Flexible options for genome-wide, pathway-focused, or user-defined gene sets to match your research objectives.

Ready to Accelerate Your Research?

Get a customized quote for your CRISPR knockout library screening project.

Technology Platform

Advanced CRISPR Knockout Technologies

State-of-the-art platforms delivering high-efficiency knockout with validated performance.

Validated sgRNA Design

Optimized sgRNA designs using established algorithms including Rule Set 2/3 for enhanced on-target activity. Multiple guides per gene ensure robust knockout efficiency.

Rule Set 2/3 CFD Scoring

High-Efficiency Delivery

Advanced lentiviral packaging systems achieve high-titer preparations (≥10^8 TU/mL) for efficient transduction across diverse cell types including primary cells.

≥10^8 TU/mL High Titer

Rigorous QC Standards

Comprehensive quality control with NGS verification ensures library uniformity, coverage, and representation across all preparations.

NGS Verified 98%+ Coverage

Multi-Guide Design Strategy

Our libraries employ a multi-guide design strategy with 4-6 sgRNAs per gene to ensure robust and consistent knockout efficiency. This approach addresses variability in sgRNA performance and provides redundant coverage for confident hit identification.

  • Higher probability of effective knockout per gene
  • Redundancy against sgRNA efficiency variation
  • Improved statistical power for screening
4-6
sgRNAs per Gene
Higher Confidence Better Coverage
Specifications

Product Specifications

Comprehensive specifications for our CRISPR knockout library products.

Library Types

Human Whole Genome
• 20,000+ protein-coding genes
• 76,000-123,000 sgRNAs
• 4-6 sgRNAs per gene
Mouse Whole Genome
• 20,000+ protein-coding genes
• 86,000+ sgRNAs
• 4-6 sgRNAs per gene
Targeted Subpools
• Kinases, GPCRs, Transcription Factors
• Epigenetic regulators
• Custom gene sets available

Technical Parameters

Vector System
• 3rd generation lentiviral vectors
• All-in-one or two-vector options
• Multiple selection markers
Quality Standards
• Lentiviral titer: ≥10^8 TU/mL
• Library coverage: ≥98%
• NGS verification included
Delivery Formats
• Plasmid DNA
• Lentiviral particles
• Arrayed plates (384-well)

Species Coverage

Species Gene Coverage sgRNA Count Format
Human 20,000+ 76,000-123,000 Plasmid / Virus / Arrayed
Mouse 20,000+ 86,000+ Plasmid / Virus / Arrayed
Rat Available Custom Plasmid / Virus
Custom Species On request Custom Custom
Workflow

Screening Workflow

A streamlined end-to-end process from library delivery to hit identification.

Step 1

Library Preparation

Receive high-titer lentiviral library with NGS QC report. Amplify library if needed following our validated protocol.

Step 2

Cell Transduction

Transduce Cas9-expressing cells at low MOI (0.3-0.6) to ensure single sgRNA per cell. Maintain 200-500x coverage.

Step 3

Selection & Screening

Apply phenotypic selection (drug treatment, FACS, survival) based on your experimental design.

Step 4

NGS & Analysis

Extract genomic DNA, amplify sgRNA regions, and perform Illumina NGS for sgRNA abundance quantification.

Step 5

Hit Identification

Bioinformatic analysis using MAGeCK or similar tools to identify enriched/depleted genes from screen data.

Applications

Diverse Applications Across Research

Our CRISPR knockout libraries support research and development across multiple fields.

Drug Discovery & Target Identification

Identify and validate therapeutic targets through genome-wide loss-of-function screening. Our libraries enable systematic interrogation of genetic dependencies for novel drug target discovery.

  • Synthetic lethality screening
  • Drug resistance mechanism discovery
  • Target validation and prioritization
  • Biomarker identification
20K+
Genes Screened Simultaneously

Oncology Research

Discover cancer vulnerabilities and resistance mechanisms through systematic genetic screening. Identify essential genes and synthetic lethal interactions for therapeutic development.

  • Cancer dependency mapping
  • Combination therapy discovery
  • Tumor microenvironment studies
  • Immunotherapy target discovery
Comprehensive
Cancer Cell Line Compatibility

Functional Genomics

Systematically characterize gene function across the genome. Our libraries enable comprehensive functional annotation for understanding biological pathways and cellular mechanisms.

  • Essential gene identification
  • Pathway analysis
  • Genetic interaction mapping
  • Cellular phenotype characterization
High-Resolution
Genome-Wide Functional Analysis
Testimonials

What Our Clients Say

Trusted by researchers worldwide for quality and reliability.

"The library quality exceeded our expectations. Consistent coverage and uniform distribution across all samples. NGS verification reports were comprehensive and helped us validate our screening results."

S
Senior Scientist
Pharmaceutical Company

"The multi-guide design significantly improved our hit detection rate. Customer support was responsive and provided valuable technical guidance throughout our screening project."

R
Research Director
Academic Research Institution

"Successfully identified novel drug targets in our oncology screening. The library coverage and delivery format made the entire workflow straightforward and efficient."

P
Principal Investigator
Biotechnology Company
Scientific Literature

Scientific Foundation

Our platform is backed by peer-reviewed research.

316 Citations

CRISPR-Cas9 Library Screening Approach for Anti-Cancer Drug Discovery: Overview and Perspectives

Chan YT, Lu Y, Wu J, Zhang C, et al. Theranostics. 2022;12(7):3329-3344.

Comprehensive review of CRISPR-Cas9 pooled library screening technology for anti-cancer drug discovery, covering positive and negative selection methods, experimental models, and target identification applications.

View DOI
42 Citations

Protocol for Performing Pooled CRISPR-Cas9 Loss-of-Function Screens

Mathiowetz AJ, Roberts MA, Morgens DW, Olzmann JA, Li Z. STAR Protocols. 2023;4(2):102201.

Detailed protocol for designing, amplifying, and screening pooled CRISPR-Cas9 knockout libraries in mammalian cells, including phenotypic selection and NGS analysis.

View DOI
28 Citations

CRISPR-Suppressor Scanning for Systematic Discovery of Drug Resistance Mutations

Ngan DK, et al. Current Protocols. 2023.

Framework for performing pooled CRISPR-Cas9 tiling mutagenesis screens with drug selection to identify drug resistance mutations, including sgRNA library design and analysis.

View DOI
15 Citations

Perturbomics: CRISPR–Cas Screening-Based Functional Genomics Approach for Drug Target Discovery

Multiple authors. Experimental & Molecular Medicine. 2025;57:1443-1454.

Review of CRISPR-based perturbomics advances including single-cell analyses, synthetic lethality interactions, and therapeutic target discovery for cancer and other diseases.

View DOI
12 Citations

Genome-Scale CRISPR-Cas9 Screening in Stem Cells: Theories, Applications and Challenges

Multiple authors. Stem Cell Research & Therapy. 2024.

Comprehensive review of CRISPR-based functional genomics screening applications in stem cells, covering library design, screening protocols, and therapeutic applications.

View DOI
FAQ

Frequently Asked Questions

Find answers to common questions about our CRISPR knockout library services.

We offer both pooled lentiviral libraries and arrayed format libraries. Pooled libraries are ideal for genome-wide negative and positive selection screens, while arrayed libraries enable high-content phenotypic screening without NGS deconvolution. We provide human, mouse, and rat genome-wide libraries as well as targeted subpools (kinases, GPCRs, transcription factors, etc.) and custom library design services.
Our standard libraries include 4-6 sgRNAs per gene, designed using validated algorithms (Rule Set 2/3) for optimal on-target activity and minimal off-target effects. This multi-guide approach ensures robust knockout efficiency and provides redundancy against sgRNA efficiency variation, improving statistical power for screening experiments.
All libraries undergo rigorous quality control including: NGS verification to confirm library representation and uniformity (≥98% coverage), functional titer testing for lentiviral preparations (≥10^8 TU/mL), and insert validation by PCR. Each delivery includes a comprehensive QC report documenting these quality metrics.
Yes, we offer comprehensive custom library design services. You can provide specific gene lists for pathway-focused or disease-relevant libraries, or request modifications to existing library formats. Our team can also assist with sgRNA design optimization for unique species or specific genomic targets. Contact us to discuss your custom library requirements.
Our lentiviral libraries are compatible with all cells that can be transduced, including dividing and non-dividing cells, primary cells, and difficult-to-transfect cell types. For optimal results, we recommend using cells that stably express Cas9. We also offer pre-packaged all-in-one systems where Cas9 is included in the viral vector for immediate use.
We provide comprehensive support including Illumina sequencing primer sets optimized for minimal bias, detailed protocols for NGS library preparation, and analysis guidelines using established tools like MAGeCK. Our technical team can also provide consultation on experimental design, statistical analysis approaches, and hit validation strategies.

Ready to Start Your Project?

Get a customized quote for your CRISPR/Cas9 Knockout Libraries project. Our experts will respond within 24 hours.

No obligation
24h response
Expert consultation